Accordingly, SCLCs in genetically engineered mouse models could not give rise to the POU2F3+ SCLC-P variant when the tumour was initiated in either PNECs, club cells or alveolar cells using cell type-specific promoters. The gene discussed is POU2F3; the disease is small cell lung carcinoma.